drugs

Bristol-Myers, Wyeth Post Higher 2Q Profits >BMY WYE - Wall Street Journal
ReutersBristol-Myers, Wyeth Post Higher 2Q Profits >BMY WYEWall Street JournalBoth companies faced headwinds from unfavorable currency-exchange rates, the weak economy and competition from cheaper generic drugs. ...Bristol-Myers Buys Medarex Drugmaker for $2.4 BillionBloombergThe Way Pharma Lives Now: Bristol's $2.1 Billion Medarex DealWall Street Journal BlogsBristol Myers says to buy Medarex for $2.1BThe Associated PressReuters�-Wall Street Journal�-Bloombergall 325 news articles��